2016
DOI: 10.1007/978-1-4939-6472-7_6
|View full text |Cite
|
Sign up to set email alerts
|

Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii

Abstract: Efficient and site-specific alteration of the genome is key to decoding and altering the genomic information of an organism. Over the last couple of years, the RNA-guided Cas9 nucleases derived from the prokaryotic type 2 CRISPR (clustered regularly interspaced short palindromic repeats) systems have drastically improved our ability to engineer the genomes of a variety of organisms including Toxoplasma gondii. In this chapter, we describe detailed protocols for using the CRISPR/Cas9 system adapted from Strepto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
120
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 106 publications
(121 citation statements)
references
References 47 publications
0
120
0
1
Order By: Relevance
“…CRISPR/Cas9-sgRNA plasmids designed to target near the 3’ end of CaM genes were generated with Q5 DNA mutagenesis (S1C Fig), using guidelines described previously [31, 65] and co-transfected with their corresponding 6HA tag amplicons containing 42 bp homology regions matching the gene of interest (Fig 1A). Resistant clones were isolated, confirmed by PCR, and tested by immunofluorescence assay (IFA).…”
Section: Resultsmentioning
confidence: 99%
“…CRISPR/Cas9-sgRNA plasmids designed to target near the 3’ end of CaM genes were generated with Q5 DNA mutagenesis (S1C Fig), using guidelines described previously [31, 65] and co-transfected with their corresponding 6HA tag amplicons containing 42 bp homology regions matching the gene of interest (Fig 1A). Resistant clones were isolated, confirmed by PCR, and tested by immunofluorescence assay (IFA).…”
Section: Resultsmentioning
confidence: 99%
“…We recently engineered an RHΔ hxgprt Δ ku80 line of T. gondii to stably express TIR1 from Oryza sativa (RH TIR1-3FLAG) (Brown et al ., 2017; Long et al ., 2017a). In this background, we were able to use CRISPR/Cas9 genome editing (Shen et al ., 2014; Sidik et al ., 2014; Shen et al ., 2017) to tag essential T. gondii genes of interest with AID-3HA or mini-AID(mAID)-3HA, regulate their expression with auxin, and identify phenotypes associated with their loss (Brown et al ., 2017; Long et al ., 2017a and 2017b). …”
Section: Introductionmentioning
confidence: 99%
“…The CRISPR-Cas9 system provides a novel and promising tool for editing T. gondii genes (Shen et al, 2014) and the genome (Sidik et al, 2014; Wang et al, 2016a; Shen et al, 2017). Using CRISPR-Cas9 to target T. gondii 's GRA genes may ultimately offer a new approach to achieving functional cure to toxoplasmosis.…”
Section: Introductionmentioning
confidence: 99%